Key Launches Ahead But Vifor Plots More Pipeline Deals
Solid 2020 In Spite Of COVID-19 Impact
Stefan Schulze, CEO of the Swiss iron deficiency and kidney disease specialist, tells Scrip that Vifor's reputation as a go-to industry partner should result in at least two more licensing deals or product acquisitions in 2021.
